Sign in

or Register now

ChronicPainConnection.com

See all of our health sites at www.HealthCentral.com
Thursday, July, 09, 2009
  • Font size

Will Cymbalta Become the Second Drug Approved for Fibromyalgia?

Karen Lee Richards
Karen Lee Richards
Close
Co-Founder of the National Fibromyalgia Assn.

Karen Lee Richards’ career as a writer and patient advocate grew...

Karen Lee Richards

Saturday, September 01, 2007
View All of Karen Lee Richards's Posts

Safe Medication Use

Learn the safest practices for medication use and what to ask your doctor.

Download Guide
Eli Lilly and Co. recently submitted a supplemental new drug application to the U.S. Food and Drug Administration requesting that Cymbalta (duloxetine) be approved for the management of fibromyalgia. Cymbalta belongs to a class of drugs known as SNRIs (serotonin and norepinephrine reuptake inhibitors) and is currently approved for adults for the treatment of major depressive disorder, diabetic peripheral neuropathic pain, and generalized anxiety disorder.

In the most recent of five clinical trials, Cymbalta was tested on fibromyalgia patients both with and without depression. The study results suggest that FM patients treated with 60mg or 120mg of Cymbalta experienced greater reduction in pain severity beginning one week after starting the drug than those receiving the placebo. At three and six months, patients showed a significantly greater reduction in pain and improvement in how they felt overall.

The most common side effects reported during the study were: nausea, dry mouth, constipation, sleepiness, fatigue, insomnia, decreased appetite, excessive perspiration, cough, tremor, rash and weight gain. Learn more about Cymbalta.

  • Font size
  • Bookmark
  • Thank you for your input
  • Save
  • RSS
  • Report Abuse
This video explains where back pain stems from by taking you through the anatomy of the back. 

Ask a Question

Get answers from our experts and community members.

View all questions (3412) >
Free Newsletter
Get weekly updates, news alerts and more on Chronic Pain and related health conditions.